In the last trading session, 1.02 million shares of the Tandem Diabetes Care Inc (NASDAQ:TNDM) were traded, and its beta was 1.16. Most recently the company’s share price was $31.73, and it changed around $1.3 or 4.27% from the last close, which brings the market valuation of the company to $2.05B. TNDM currently trades at a discount to its 52-week high of $40.92, offering almost -28.96% off that amount. The share price’s 52-week low was $13.82, which indicates that the current value has risen by an impressive 56.45% since then. We note from Tandem Diabetes Care Inc’s average daily trading volume that its 3-month average coming to 1.74 million.
Tandem Diabetes Care Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.11. If we narrow it down even further, the data shows that 1 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 5 recommended TNDM as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Tandem Diabetes Care Inc is expected to report earnings per share of $Tandem Diabetes Care, Inc. for the current quarter.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Instantly TNDM has showed a green trend with a performance of 4.27% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 7.27% year-to-date, but still down -0.41% over the last five days. On the other hand, Tandem Diabetes Care Inc (NASDAQ:TNDM) is -0.41% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $102.5, which translates to bulls needing to increase their stock price by 69.04% from its current value. Analyst projections state that TNDM is forecast to be at a low of $36 and a high of $160.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Tandem Diabetes Care Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 62.63 percent over the past six months and at a -3.18% annual growth rate that is well below the industry average of 14.60%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -6.11%.
TNDM Dividends
Tandem Diabetes Care Inc’s next quarterly earnings report is expected to be released on May 02.
